Epidemiol Health.
2025;47(1):e2025005. 10.4178/epih.e2025005.
Prevalence of cardiovascular-kidney-metabolic syndrome in Korea: Korea National Health and Nutrition Examination Survey 2011-2021
- Affiliations
-
- 1Department of Biology Education, Seoul National University, Seoul, Korea
- 2Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
- 3Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul, Korea
- 4Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine Seoul, Korea
- 5Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
- 6Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea
- 7BK21Plus Biomedical Science Project, Seoul National University College of Medicine, Seoul, Korea
- 8Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul, Korea
- 9Cancer Research Institute, Seoul National University, Seoul, Korea
- KMID: 2567686
- DOI: http://doi.org/10.4178/epih.e2025005
Abstract
OBJECTIVES
The American Heart Association (AHA) recently defined cardiovascular-kidney-metabolic (CKM) syndrome to better characterize the associations among cardiovascular, kidney, and metabolic diseases. Although about 9 in 10 United States adults have at least 1 risk factor for CKM syndrome, its prevalence in other populations is less understood. To fill this gap, we examined the prevalence of CKM syndrome in Korea and its association with demographic and socioeconomic status (SES).
METHODS
Using data from the Korean National Health and Nutrition Examination Survey between 2011 and 2021, we calculated the prevalence of CKM syndrome across the following stages: stage 0 (no risk factors), stage 1 (excess or dysfunctional adiposity), stage 2 (other metabolic risk factors or chronic kidney disease), and stages 3-4 (subclinical/clinical cardiovascular diseases) among adults aged ≥20 years. Weighted analyses were used to estimate prevalence and 95% confidence intervals (CIs) for each CKM syndrome stage, stratified by age, gender, and SES factors.
RESULTS
Among 54,994 Korean adults, the prevalence of CKM syndrome was as follows: stage 0 (25.2%; 95% CI, 24.7 to 25.8), stage 1 (19.3%; 95% CI, 18.9 to 19.7), stage 2 (51.6%; 95% CI, 51.1 to 52.2), and stages 3-4 (3.9%; 95% CI, 3.7 to 4.0). The prevalence of stages 2 and 3-4 was higher in men than in women. In addition, stages 3-4 were more prevalent among rural residents and those with lower education or income.
CONCLUSIONS
About 3 out of 4 Koreans are at risk for CKM syndrome. These findings highlight that CKM syndrome is a global health problem and that interventions are urgently needed to prevent further progression.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Evaluation of Metabolic Syndrome in Patients with Chronic Low Back Pain: Using the Fourth Korea National Health and Nutrition Examination Survey Data
- The Association between Consumption of Processed Meat and Prevalence of Metabolic Syndrome Among Korean Adults: Based on 2007-2008 Korean National Health and Nutrition Examination Survey
- Sex-specific impact of the COVID-19 outbreak on the incidence of metabolic syndrome: a comparative study of 2018–2019 and 2020–2021
- Relationship between Kimchi and Metabolic Syndrome in Korean Adults: Data from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2007~2012
- Prevalence of the Metabolic Syndrome in Korean Children and Adolescents according to the International Diabetes Federation Definition in Children and Adolescents
